IPR ,318, Dec-13 PRISM Pharma Co., Ltd. CHOONGWAE PHARMA CORP. N/A Settled pre-institution N/A

Transcription

1 Trial Drug (if applicable) Patent No. Filed Date Petitioner(s) Patent Owner(s) Inst. Dec. Outcome Details of FWD <Information obtained primarily from Lex Machina and public sources on the Internet. If any errors are identified, please contact Lisa Mandrusiak at Oblon.> Enzymotec USA, Inc.; IPR ,278,351 1-Oct-13 Enzymtoec Ltd.; Aker BioMarien ASA Bioressources Inc. Instituted Final written decision Some claims upheld IPR Tygacil 7,879,828 1-Nov-13 Apotex Holdings, Inc.; Apotex Inc. Wyeth LLC Instituted Final written decision All inst. claims upheld IPR ,383,675 7-Nov-13 Aker BioMarine ASA IPR Opana ER 7,851, Nov-13 Amneal Pharmaceuticals LLC; Amneal Pharmaceuticals of New York LLC Endo Pharmaceuticals, Inc. Instituted Claims disclaimed N/A IPR ,318, Dec-13 PRISM Pharma Co., Ltd. CHOONGWAE PHARMA CORP. N/A Settled pre-institution N/A IPR Suboxone 8,475, Jan-14 BioDelivery Sciences International, Inc. RB Pharmaceuticals Ltd. Instituted Final written decision All inst. claims unpatentable IPR ,312,672 8-Jan-14 EI Dupont De Nemours and Co. Monsanto Technology LLC Denied N/A N/A IPR ,071,845 8-Jan-14 EI Dupont De Nemours and Co. Monsanto Technology LLC Denied N/A N/A IPR ,832,143 8-Jan-14 EI Dupont De Nemours and Co. Monsanto Technology LLC Denied N/A N/A IPR Opana ER 8,329, Jan-14 Amneal Pharmaceuticals LLC Endo Pharmaceuticals, Inc. Instituted Final written decision All inst. claims upheld IPR Opana ER 8,309, Jan-14 Amneal Pharmaceuticals LLC Endo Pharmaceuticals, Inc. Denied Time barred N/A IPR Onsolis ; Bunavail ; Belbuca 7,579, Jan-14 MonoSol Rx LLC Arius Two, Inc. Instituted Final written decision All inst. claims upheld IPR IPR Jentadueto XR 6,635, Jan-14 Purdue Pharma L.P. Depomed, Inc. Instituted Final written decision All inst. claims upheld Jentadueto XR 6,340, Jan-14 Purdue Pharma L.P. Depomed, Inc. Instituted Final written decision All inst. claims upheld

2 IPR Jentadueto XR 6,340, Jan-14 Purdue Pharma L.P. Depomed, Inc. Instituted Final written decision All inst. claims upheld IPR ,728, Jan-14 LENROC COMPANY Enviro Tech Cehmical Services, Inc. Denied N/A N/A IPR ,299, Jan-14 3-D Matrix, Ltd. Menicon Co. Ltd. Denied N/A N/A IPR ,354, Feb-14 Complete Nutrition Holdings Inc. Vireo Systems, Inc; Board of Regents of the University of Nebraska Instituted Settled post-institution N/A IPR ,383, Feb-14 Enzymotec Ltd. IPR ,974, Mar-14 Conopco, Inc. dba Unilever The Procter & Gamble Co. Denied N/A N/A IPR ,451, Mar-14 Conopco, Inc. dba Unilever The Procter & Gamble Co. Denied N/A N/A University of Washington; Oxford Nanopore UAB Research Foundation; IPR ,673, Mar-14 Technologies Ltd. The Illumina, Inc. Denied N/A N/A IPR ,673, Mar-14 Oxford Nanopore Technologies Ltd. University of Washington; UAB Research Foundation; The Illumina, Inc. Instituted Claims disclaimed; final written decision Some claims upheld IPR Exelon 6,316,023 2-Apr-14 IPR Exelon 6,335,031 2-Apr-14 Noven Pharmaceuticals, Inc.; Mylan Pharmaceuticals, Inc. Noven Pharmaceuticals, Inc.; Mylan Pharmaceuticals, Inc. Novartis AG; LTS Lohmann Therapie-Systeme AG Instituted Final written decision All inst. claims unpatentable LTS Lohmann Therapie- Systeme AG; Novartis AG Instituted Final written decision All inst. claims unpatentable IPR ,448,274 1-Apr-14 Torrent Pharmaceuticals Ltd. Merck Frosst Canada & Co. Denied N/A N/A IPR ,278,351 4-Apr-14 Enzymotec Ltd.; Enzymotec USA, Inc. Bioressources Inc. Instituted Final written decision All inst. claims unpatentable IPR ,273,565 4-Apr-14 Butamax (TM) Advanced Biofules LLC Gevo Inc. Denied N/A N/A IPR ,278, Apr-14 Enzymotec Ltd. IPR ,649, Apr-14 Conopco, Inc. dba Unilever The Procter & Gamble Co. Denied N/A N/A IPR ,278, Apr-14 Enzymotec Ltd. IPR Invokamet XR 6,723, Apr-14 Endo Pharmaceuticals, Inc. Depomed, Inc. Denied N/A N/A

3 IPR IPR IPR IPR Invokamet XR 6,723, Apr-14 Endo Pharmaceuticals, Inc. Depomed, Inc. Instituted Final written decision All inst. claims unpatentable Jentadueto XR 6,340, Apr-14 Endo Pharmaceuticals, Inc. Depomed, Inc. Denied N/A N/A Jentadueto XR 6,340, Apr-14 Endo Pharmaceuticals, Inc. Depomed, Inc. Instituted Final written decision All inst. claims upheld Jentadueto XR 6,635, Apr-14 Endo Pharmaceuticals, Inc. Depomed, Inc. Denied N/A N/A IPR Jentadueto XR 6,635, Apr-14 Endo Pharmaceuticals, Inc. Depomed, Inc. Instituted Final written decision All inst. claims upheld IPR ,337, Apr-14 Phigenix, Inc. ImmunoGen, Inc. Instituted Final written decision All inst. claims upheld IPR ,133, Apr-14 Lilly USA, LLC; Eli Lilly & Co. Los Angeles Biomedical Research Inst. at Harbor-UCLA Medical Center Instituted Final written decision All inst. claims upheld IPR Astepro 8,071,073 7-May-14 Impax Laboratories, Inc. Meda Pharmaceuticals Inc. N/A Settled pre-institution N/A IPR ,318,813 9-May-14 Shire Development LLC Lucerne Biosciences, LLC; LCS Group, LLC Instituted Claims disclaimed N/A IPR ,133, May-14 Lilly USA, LLC; Eli Lilly & Co. Los Angeles Biomedical Research Inst. at Harbor-UCLA Medical Center Instituted Final written decision All inst. claims unpatentable IPR Gilenya 8,324, May-14 Torrent Pharmaceuticals Ltd.; Mylan Pharmaceuticals, Inc.; Apotex Inc. Mitsubishi Tanabe Pharma Corp.; Novartis AG Instituted Final written decision All inst. claims unpatentable IPR ,989, May-14 CAO Group The Procter & Gamble Co. Denied N/A N/A IPR ,045, May-14 CAO Group The Procter & Gamble Co. Denied N/A N/A IPR ,122, May-14 CAO Group The Procter & Gamble Co. Denied N/A N/A IPR ,575, May-14 Phigenix, Inc. ImmunoGen, Inc.; Genentech, Inc. Denied N/A N/A

4 IPR Glucotrol XL RE May-14 PACK Pharmaceuticals, LLC Alza Corporation N/A Settled pre-institution N/A IPR Trizivir ; Epzicom ; Triumeq 6,417,191 2-Jun-14 Apotex Inc. ViiV Healthcare Co.; Viiv Healthcare UK Ltd. Instituted Settled post-institution N/A IPR Atripla 5,922,695 4-Jun-14 Mylan Pharmaceuticals, Inc. Gilead Sciences, Inc. Denied N/A N/A IPR Atripla 5,935,946 4-Jun-14 Mylan Pharmaceuticals, Inc. Gilead Sciences, Inc. Denied N/A N/A IPR Atripla 5,977,089 4-Jun-14 Mylan Pharmaceuticals, Inc. Gilead Sciences, Inc. Denied N/A N/A IPR Atripla 6,043,230 4-Jun-14 Mylan Pharmaceuticals, Inc. Gilead Sciences, Inc. Denied N/A N/A IPR ,462,180 4-Jun-14 Baxter Healthcare Corp; Kamada, Ltd. Grifols, Inc.; Grifols S.A.; Grifols Therapeutics, Inc. Instituted Final written decision All inst. claims unpatentable IPR ,372, Jun-14 Luminex Corp. Irori Technologies, Inc. Instituted Settled post-institution N/A IPR ,416, Jun-14 Luminex Corp. Irori Technologies, Inc. Instituted Settled post-institution N/A IPR ,352, Jun-14 Luminex Corp. Irori Technologies, Inc. Instituted Settled post-institution N/A IPR ,352, Jun-14 Luminex Corp. Irori Technologies, Inc. Instituted Settled post-institution N/A IPR ,352, Jun-14 Luminex Corp. Irori Technologies, Inc. Instituted Settled post-institution N/A IPR ,884, Jun-14 IPR ,574, Jun-14 IPR Suboxone 8,475, Jun-14 IPR Prolensa 8,129, Jun-14 IPR Prolensa 8,669, Jun-14 Enviro Granulation, LTD; Plant Science, Inc. The Andersons, Inc. Denied N/A N/A Enviro Granulation, LTD; Plant Science, Inc. The Andersons, Inc. Denied N/A N/A BioDelivery Sciences International, Inc. RB Pharmaceuticals Ltd. Denied N/A N/A Senju Pharmaceutical Co.; Johnson Mattey Inc.; Mayne Bausch & Lomb Pharma Pharma Group Ltd.; Metrics, Holdings Copr.; Bausch & Inc. Lomb Inc. Instituted Settled post-institution N/A Johnson Mattey Inc.; Mayne Pharma Group Ltd.; Metrics, Inc. Senju Pharmaceutical Co.; Bausch & Lomb Pharma Holdings Copr.; Bausch & Lomb Inc. Instituted Settled post-institution N/A LEO Pharma, Inc.; LEO Pharma Medac Gesellschaft Fur IPR Rasuvo 8,664,231 1-Jul-14 A/S; Antares Pharma Inc. Klinische Instituted Settled post-institution N/A IPR ,955,794 2-Jul-14 Ariosa Diagnostics, Inc. Illumina, Inc. Instituted Final written decision All inst. claims upheld

5 IPR Vimpat RE Jul-14 IPR ,455, Jul-14 Amneal Pharmaceuticals, LLC; Venno; Aurobindo Pharma USA Inc.; Breckenridge Pharmaceutical, Inc.; et al. Research Corporation Technologies Inc. Denied N/A N/A John's Lone Star Distribution, Inc. Thermolife Internatioanl, LLC Instituted Settled post-institution N/A IPR Tygacil 7,879,828 8-Aug-14 Initiative for Responsibility in Drug Pricing LLC Wyeth LLC Denied N/A N/A IPR ,048, Aug-14 Instituto Bioclon S.A. de C.V.; Laboratorios Silanes, S.A. de C.V.; Rare Disease Therapeutics Inc. BTG International Inc. N/A Settled pre-institution N/A IPR ,501, Aug-14 Merial Ltd. Virbac SA Instituted Claims disclaimed N/A IPR ,058, Aug-14 BioGateKeeper, Inc. Kyoto University Denied N/A N/A IPR ,838, Aug-14 GeneDx, Inc. Myriad Genetics N/A Settled pre-institution N/A IPR ,670, Aug-14 GeneDx, Inc. Myriad Genetics N/A Settled pre-institution N/A IPR ,563, Aug-14 GeneDx, Inc. Myriad Genetics N/A Settled pre-institution N/A IPR ,622, Aug-14 GeneDx, Inc. Myriad Genetics N/A Settled pre-institution N/A IPR ,033, Aug-14 GeneDx, Inc. Endorecherche; Trustees of the Univ. of Pennsylvania; University of Utal Research Foundation; et al. N/A Settled pre-institution N/A IPR ,083, Aug-14 GeneDx, Inc. Myriad Genetics N/A Settled pre-institution N/A IPR ,051, Aug-14 GeneDx, Inc. Myriad Genetics N/A Settled pre-institution N/A IPR ,951, Aug-14 GeneDx, Inc. Myriad Genetics N/A Settled pre-institution N/A IPR ,470, Aug-14 GeneDx, Inc. Myriad Genetics N/A Settled pre-institution N/A IPR ,753, Aug-14 Bio-Reference Laboratories, Inc.; GeneDx, Inc. University of Utah Research Foundation N/A Settled pre-institution N/A IPR Opana ER 8,329, Aug-14 Amneal Pharmaceuticals of New York LLC; Amneal Pharmaceuticals LLC Endo Pharmaceuticals, Inc. Instituted Final written decision All inst. claims upheld IPR ,450, Aug-14 Galderma SA; Q-Med AB Allergan, Inc.; Allergan Industrie SAS; Allergan Peurto Rico Holdings Inc.; Allergan Sales, LLC; et al. Denied N/A N/A IPR ,357, Aug-14 Galderma SA; Q-Med AB Allergan Industrie SAS Denied N/A N/A IPR ,197, Sep-14 S.S. Steiner, Inc. John I. Haas, Inc. Denied N/A N/A IPR ,090, Sep-14 S.S. Steiner, Inc. John I. Haas, Inc. Denied N/A N/A IPR ,076, Sep-14 Daicel Corporation Celanese International Corp. Denied N/A N/A

6 IPR ,223, Sep-14 Daicel Corporation Celanese International Corp. Denied N/A N/A IPR ,820, Sep-14 ABS Global, Inc. XY, LLC Instituted Final written decision All inst. claims unpatentable L. Perrigo Company; Perrigo Brigham and Women's IPR ,229, Sep-14 Company Hospital, Inc. Denied N/A N/A